Analysis of multiple endpoints
Sunday afternoon, July, 8Abstract:
This course will focus on issues arising in clinical trials with multiple endpoints, including analysis of multiple co-primary endpoints (overall analysis and analysis of individual variables) and analysis of primary endpoints in the presence of important secondary endpoints/secondary analyses (gatekeeping strategies). It provides a detailed overview of well-established methods as well as novel statistical approaches developed over the past five years. The course offers a well-balanced mix of theory and applications, including regulatory considerations and software implementation of the described statistical methods. Examples from real trials are used throughout the discussion to illustrate the statistical approaches discussed in the course.
Alex Dmitrienko, Ph.D., is Principal Research Scientist, Eli Lilly and Company. He received his PhD in statistics from the University of Kentucky in 1998 and joined Eli Lilly and Company that year. He has been working on multiplicity issues arising in clinical trials since 1999 and written several papers/chapters on topics related to multiple testing. His recently published SAS Press book, "Analysis of Clinical Trials Using SAS: A Practical Guide", (written jointly with G. Molenberghs, University Hasselt; C. Chuang-Stein, Pfizer; W. Offen, Lilly) focuses on key problems arising in the context of clinical trials, including the analysis of multiple comparisons and multiple endpoints. He has also served as an editor (jointly with C. Chuang-Stein, Pfizer; Ralph D'Agostino, Boston University) of another SAS Press book, "Pharmaceutical Statistics Using SAS", that will be published in late 2006. Alex serves as an Associate Editor for Statistics in Medicine and The American Statistician.
Dmitrienko A, Molenberghs G, Chuang-Stein C, Offen W. Analysis of Clinical
Trials Using SAS: A Practical Guide. SAS Press: Cary, NC, 2005.